Analytical Data
-
Gene name
BENE
- Application
-
Alternative Names
MALL; BENE; MAL-like Protein; Protein BENE
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q13021
-
Expression Region
1-153aa
-
AA Sequence
MASPDPPATSYAPSDVPSGVALFLTIPFAFFLPELIFGFLVWTMVAATHIVYPLLQGWVMYVSLTSFLISLMFLLSYLFGFYKRFESWRVLDSLYHGTTGILYMSAAVLQVHATIVSEKLLDPRIYYINSAASFFAFIATLLYILHAFSIYYH
-
Molecular Weight
42.57 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BENE is a recombinant protein that has garnered significant interest in the field of biotechnology and pharmaceuticals. The research into BENE stems from the need to understand its structure and function, as well as its potential applications in therapeutic development. The protein is derived from a specific biological source, which gives it unique properties that may be beneficial in treating various diseases. Scientists are particularly focused on elucidating the mechanisms by which BENE interacts with cellular pathways, as this knowledge could lead to innovative treatments for conditions such as cancer and autoimmune disorders. Additionally, BENE's ability to stimulate immune responses makes it a candidate for vaccine development. As the demand for effective and targeted therapies continues to rise, BENE represents a promising avenue for research aimed at enhancing the efficacy of existing treatments and paving the way for new therapeutic strategies. Collaborative efforts across multiple disciplines, including molecular biology, biochemistry, and pharmacology, are crucial to advancing our understanding of BENE and unlocking its full potential in medical applications.
